Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
Abstract Background Significant amount of bone mass is lost during the process of aging due to an imbalance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption in bone marrow microenvironment, which leads to net bone loss in the aging population, resulting in the patho...
Main Authors: | Xia Chen, Junsong Chen, Dongliang Xu, Shuangxia Zhao, Huaidong Song, Yongde Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12891-017-1779-7 |
Similar Items
-
Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
by: Xiang Hu, et al.
Published: (2018-03-01) -
Effect of Salicornia herbacea on Osteoblastogenesis and Adipogenesis in Vitro
by: Fatih Karadeniz, et al.
Published: (2014-10-01) -
Effect of Quercetin 3-<i>O</i>-β-D-Galactopyranoside on the Adipogenic and Osteoblastogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stromal Cells
by: Jung Hwan Oh, et al.
Published: (2020-10-01) -
Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway
by: Xu T, et al.
Published: (2019-12-01) -
Senile Osteoporosis: The Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells
by: Abdul Qadir, et al.
Published: (2020-01-01)